Synthetic biology and precision medicine in blood and gynaecological cancers
Kerstin Forsberg an information architect from AstraZeneca discusses her role in documenting the safety and efficacy of medicines used in clinical trials. She talks about the potential of improvements to healthcare and research capabilities through the use of semantic web technology.
To find out more about the EURECA project visit http://eurecaproject.eu/
Synthetic biology and precision medicine in blood and gynaecological cancers
Early-stage breast cancer detection in breast milk
Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Breast and emerging indications for IORT
The advantages of IORT for early breast cancer treatment
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours